Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Net Margin (2020 - 2024)

Roivant Sciences (ROIV) has disclosed Net Margin for 5 consecutive years, with 3626.3% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Net Margin rose 378386.0% year-over-year to 3626.3%, compared with a TTM value of 2563.05% through Sep 2025, up 322218.0%, and an annual FY2025 reading of 1284.5%, changed N/A over the prior year.
  • Net Margin was 3626.3% for Q4 2024 at Roivant Sciences, up from 5292.54% in the prior quarter.
  • Across five years, Net Margin topped out at 3626.3% in Q4 2024 and bottomed at 8191.34% in Q2 2022.
  • Average Net Margin over 5 years is 1900.42%, with a median of 1306.76% recorded in 2021.
  • The sharpest move saw Net Margin plummeted -688458bps in 2022, then skyrocketed 667522bps in 2023.
  • Year by year, Net Margin stood at 155.06% in 2020, then tumbled by -329bps to 664.49% in 2021, then plummeted by -240bps to 2257.19% in 2022, then soared by 93bps to 157.55% in 2023, then surged by 2402bps to 3626.3% in 2024.
  • Business Quant data shows Net Margin for ROIV at 3626.3% in Q4 2024, 5292.54% in Q3 2024, and 395.53% in Q2 2024.